Amblyopia, often called lazy eye, is a condition that occurs when there is a reduction of vision in one eye that is not correctable with glasses.
There are 2 common types of amblyopia:
The sooner amblyopia is treated, the more favorable the outcome.
Amblyopia is caused when the brain prefers (favors) one eye to the other. The brain’s preference (liking) for one eye over the other can weaken and reduce vision in the eye that is less used.
There are no apparent genetic or environmental factors that can be attributed to causing amblyopia.
Amblyopia is more common in children under 10 years old with:
Amblyopia can also occur in adults.
Some people with amblyopia may not have symptoms. In those that have them, amblyopia may cause:
Symptoms vary depending on the extent of the amblyopia.
Your eye doctor will ask about your symptoms and medical history. An examination of your eyes will be done. Since amblyopia tends to occur in young children, the types of tests their eye doctor will perform will be determined by their age and ability to respond.
Tests to evaluate the eyes may include:
Treatment includes correcting visual obstructions, such as cataracts and other visual abnormalities.
Talk to your doctor about the best option for you. These may include:
Atropine drops or ointment is placed in the non-amblyopic eye. This causes the sound eye to become unfocused and forces the use of the lazy eye.
Occlusive therapy involves using a patch over the non-amblyopic eye (the sound eye), forcing the use of the lazy eye.
Bangerter foils are another option. The foils, which are made of thin vinyl, are placed over an eye glass lens, covering the non-amblyopic eye. Just like with the patch, this forces the weaker eye to become stronger because you will not be able to see well with the foiled lens.
Eye Smart—American Ophthalmology
National Eye Institute (NEI)
Canadian Ophthalmological Society
The Canadian National Institute for the Blind
Amblyopia. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T114848/Amblyopia. Updated January 8, 2016. Accessed September 26, 2016.
Bhola R, Keech RV, et al. Recurrence of amblyopia after occlusion therapy. Ophthalmology. 2006;113(11):2097-2100.
Campos, EC, Schiavi, et al. Effect of citicoline on visual acuity in amblyopia: preliminary results. Graefes Arch Clin Exp Ophthalmol.1995;233(5):307-312.
Fleck BW. Amblyopia therapy. Br J Ophthalmol. 2003;87(3):255-266.
Flynn JT, Schiffman J, et al. The therapy of amblyopia: An analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc. 1998;96: 431-450; discussion 450-453.
Holmes JM, Beck RW, et al. Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121(11):1625-1632.
Kushner BJ. Atropine vs. patching for the treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120(3):387-388.
LaRoche GR. Amblyopia: Detection, prevention, and rehabilitation. Curr Opin Ophthalmol. 2001;12(5):363-367.
Leguire LE, Rogers GL, et al. Occlusion and levodopa-carbidopa treatment for childhood amblyopia. J AAPOS.1998;2(5).
Loudon SE, Simonsz HJ. The history of the treatment of amblyopia. Strabismus. 2005;13(2):93-106.
Ohlsson J, Baumann M, et al. Long term visual outcome in amblyopia treatment. Br J Ophthalmol. 2002; 86(10):1148-51.
Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology. 2003;110(8):1632-7; discussion 1637-8.
Powell C, Porooshani H, et al. Screening for amblyopia in childhood. Cochrane Database Syst Rev. 2005;(3):CD005020.
Quinn GE, Beck RW, et al. Pediatric Eye Disease Investigator Group. Recent advances in the treatment of amblyopia. Pediatrics. 2004;113 (6):1800-1802.
Sakatani K, Jabbur NS, et al. Improvement in best corrected visual acuity in amblyopic adult eyes after laser in situ keratomileusis. J Cataract Refract Surg. 2004;30(12):2517-2521.
Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol. 2005;50(2):123-166.
5/28/2010 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T114848/Amblyopia: Pediatric Eye Disease Investigator Group Writing Committee, Rutstein RP, Quinn GE, et al. A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology. 2010;117(5):998-1004.
2/4/2011 DynaMed Plus Systematic Literature Surveillance http://www.dynamed.com/topics/dmp~AN~T114848/Amblyopia: US Preventive Services Task Force. Vision screening for children 1 to 5 years of age: US Preventive Services Task Force recommendation statement. Pediatrics. 2011;127(2):340-346.
Last reviewed December 2014 by Michael Woods, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.